Christopher J. Rapuano, MD - Chief of The Wills Eye Hospital Cornea Service discusses Corneal Collagen Cross-linking (CXL)
Cornea specialists in the US have been waiting a long time, but corneal collagen cross-linking (CXL) was finally FDA approved last year. We at Wills Eye are very excited to be able to offer this treatment to our patients with worsening keratoconus and post-refractive surgery ectasia. While there are a variety of CXL techniques, we are performing the FDA approved epithelium-off Dresden protocol with the longest track record and excellent published results.